Loading...

PLRX PLIANT THERAPEUTICS INC Operational Disruptions 8-K Filing

PLNT

PLRX

PLIANT THERAPEUTICS INC

(PLRX)

2024 8-K

Show Summary

Show Summary

Financial Statements

Management Changes

Stockholder Rights

Q4 Financial Results

Q3 Financial Results

Bylaw Amendment

Earnings Report

Positive Clinical Trial Dat...

Board Appointment and Annua...

Clinical Trial Results

Financial Results Announcement

Loan Agreement and Clinical...

Results of Operations and F...

Clinical Trial Results

Financial Results Announcement

Lease Agreement

Positive Clinical Trial Dat...

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Clinical Trial Results

Results of Operations and F...

Board Expansion and New App...

Termination of Collaboratio...

Clinical Trial Results

External Links:

Pliant Therapeutics announced positive long-term data from a Phase 2a clinical trial of bexotegrast in patients with primary sclerosing cholangitis, meeting its primary endpoint of safety and demonstrating antifibrotic and anti-cholestatic activity.

AI Assistant

PLIANT THERAPEUTICS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.